ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,937 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryZugMoonLake Immunotherapeutics AG
MoonLake Immunotherapeutics AG Logo
Verified· 3 sourcesTrust Score
Summary

About the company

The core activity of MoonLake Immunotherapeutics AG is the development of innovative therapies for inflammatory diseases, particularly with the goal of improving the treatment of diseases such as psoriasis and hidradenitis suppurativa. The company focuses on the development of Sonelokimab, a Nanobody that specifically inhibits interleukins to reduce inflammation. The core activities include conducting clinical trials, developing new therapies, and licensing medications.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

MoonLake Immunotherapeutics AG

✓ Offered1
Nanobody Therapeutics Development
Development of Nanobody-based therapies for inflammatory diseases, with clinical programs in hidradenitis suppurativa, psoriasis, psoriatic arthritis, palmoplantar pustulosis and axial spondyloarthritis.
Trust & reputation

ranQ Trust Score of MoonLake Immunotherapeutics AG: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 58% · As of October 2026

Without public customer reviews the score stays capped.

MoonLake Immunotherapeutics AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
MoonLake Immunotherapeutics AG scores 77.1 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.64.612%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.82.07%
MoonLake Immunotherapeutics AG scores 86.7 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).86.722%
MoonLake Immunotherapeutics AG scores 68.4 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.100.04%
  • Media authority: Quality and number of editorial mentions, weighted by the importance of the source, plus the recency of the latest high-quality mention.36.74%
Qualifications+0.00

MoonLake Immunotherapeutics AG reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 58%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Press

Media

July 17, 2026Media
Moonlake Therapeutics raises USD 230 million in public offering
startupticker.ch
April 3, 2025Media
MoonLake Immunotherapeutics secures up to $500 Million in non-dilutive financing
startupticker.ch

Knowledge

No knowledge articles yet

Once MoonLake Immunotherapeutics AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

MoonLake Immunotherapeutics AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank MoonLake Immunotherapeutics AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of MoonLake Immunotherapeutics AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Dorfstrasse 29
6300 Zug

At a glance

Legal form
Corporation
UID
CHE-433.093.536
Founded
2021 · 5 years
Last commercial register change
March 27, 2026
Employees
21 to 50
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    EL
    Earendil Labs AG
    Zug
    BM
    Blueprint Medicines (Switzerland) GmbH
    Zug
    PB
    Packgene Biotech AG
    Zug
    SI
    Sarepta International Holdings GmbH
    Zug
    AP
    Azurity Pharmaceuticals Switzerland GmbH
    Zug
    CL
    Centenara Labs AG
    Baar
    CT
    Celldex Therapeutics Switzerland GmbH
    Zug
    BS
    Bristol-Myers Squibb Products SA
    Steinhausen